Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Ledecq

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|May 18, 2021
Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational ApproachesAdrian Hall, Hugues Chanteux, Karelle Ménochet, et al.
The Journal of Physical Chemistry. B|March 25, 2010
Analysis of the interactions taking place in the recognition site of a bimetallic Mg(II)-Zn(II) enzyme, isopentenyl diphosphate isomerase. a parallel quantum-chemical and polarizable molecular mechanics studyNohad Gresh, Nicole Audiffren, Jean-Philip Piquemal, et al.
Journal of Medicinal Chemistry|April 28, 2006
Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IXAnne Thiry, Marie Ledecq, Alessandro Cecchi, et al.
Bioorganic & Medicinal Chemistry|December 23, 2008
Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitorsAnne Thiry, Marie Ledecq, Alessandro Cecchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2025
Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A)Anshumali Mittal, Matthew F Martin, Laurent Provins, et al.
European Journal of Medicinal Chemistry|May 16, 2008
Synthesis and biological evaluation of a new family of anti-benzylanilinosulfonamides as CA IX inhibitorsAnne Thiry, Aurélie Delayen, Laurence Goossens, et al.
Biochemical Pharmacology|May 30, 2002
Metal-organic compounds: a new approach for drug discovery. N1-(4-methyl-2-pyridyl)-2,3,6-trimethoxybenzamide copper(II) complex as an inhibitor of human immunodeficiency virus 1 proteaseFlorence Lebon, Nicole Boggetto, Marie Ledecq, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Towards a KCC2 blocker pharmacophore modelFlorence Lebon, Cécile Pégurier, Marie Ledecq, et al.
Nature Structural & Molecular Biology|March 6, 2025
Author Correction: Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsantsAnshumali Mittal, Matthew F Martin, Elena J Levin, et al.
Nature Structural & Molecular Biology|June 19, 2024
Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsantsAnshumali Mittal, Matthew F Martin, Elena J Levin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|May 18, 2021
Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational ApproachesAdrian Hall, Hugues Chanteux, Karelle Ménochet, et al.
The Journal of Physical Chemistry. B|March 25, 2010
Analysis of the interactions taking place in the recognition site of a bimetallic Mg(II)-Zn(II) enzyme, isopentenyl diphosphate isomerase. a parallel quantum-chemical and polarizable molecular mechanics studyNohad Gresh, Nicole Audiffren, Jean-Philip Piquemal, et al.
Journal of Medicinal Chemistry|April 28, 2006
Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IXAnne Thiry, Marie Ledecq, Alessandro Cecchi, et al.
Bioorganic & Medicinal Chemistry|December 23, 2008
Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitorsAnne Thiry, Marie Ledecq, Alessandro Cecchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2025
Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A)Anshumali Mittal, Matthew F Martin, Laurent Provins, et al.
European Journal of Medicinal Chemistry|May 16, 2008
Synthesis and biological evaluation of a new family of anti-benzylanilinosulfonamides as CA IX inhibitorsAnne Thiry, Aurélie Delayen, Laurence Goossens, et al.
Biochemical Pharmacology|May 30, 2002
Metal-organic compounds: a new approach for drug discovery. N1-(4-methyl-2-pyridyl)-2,3,6-trimethoxybenzamide copper(II) complex as an inhibitor of human immunodeficiency virus 1 proteaseFlorence Lebon, Nicole Boggetto, Marie Ledecq, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Towards a KCC2 blocker pharmacophore modelFlorence Lebon, Cécile Pégurier, Marie Ledecq, et al.
Nature Structural & Molecular Biology|March 6, 2025
Author Correction: Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsantsAnshumali Mittal, Matthew F Martin, Elena J Levin, et al.
Nature Structural & Molecular Biology|June 19, 2024
Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsantsAnshumali Mittal, Matthew F Martin, Elena J Levin, et al.
Pageof 1